Two new forms of treatments for Alzheimer's disease
( possible treatments )
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
The hope of the study at the Pasadena research institute is to slow or stop the disease's progress by detecting early biomarkers or signs of the disease before the onset of symptoms. Once these early signs are detected, treatments can be studied in patients with the beginning stages of AD.
"The challenge is if you have AD and are showing symptoms, it's too late," said researcher Dr. Harrington, Chief of the Molecular Neurology Program at the institute. "Some 20 years of slow brain damage has been going on without you or your family knowing it."
Alzheimer's Disease, commonly referred to as AD, effects the brain causing dementia in individuals who suffer from this terminal and incurable condition. Annually, the U.S spends $172 billion to care for people with Alzheimer's. The cause of the disease has not yet been determined, doctors say. A family history of AD can put an individual at more risk for developing symptoms, but doctors also believe environmental factors may play a role in the diseases' genetic chemistry.
The two-year study to find biological indicators of AD at Huntington Medical Research Institute will be funded by a recent grant awarded to institution.
Dr. Harrington and Director of the Magnetic Resonance Spectroscopy Program, Dr. Ross, will combine magnetic resonance spectroscopy and molecular neurology testing to study and detect biomarkers in around 120 participants between the ages of 70 and 90-years-old. Participants will range from healthy individuals, people with mild cognitive impairment and patients with the disease. Read more: sgvtribune.com
Alcohol can delay dementia
As heartbreaking and devastating as Alzheimer's is, optimism is growing that we can lessen the risk and possibly save ourselves. Read more: dailymail.co.uk
No comments:
Post a Comment